Portfolio - Linden Lake Labs - Biotech Portfolio Companies

Our Portfolio

We work with early-stage ventures built around science that matters. Our portfolio includes companies we have created, as well as early investments in startups focused on transformative therapies.

Xcellon Biologics

Xcellon is a Maryland-based CDMO specializing in complex biologics, including ADCs, bispecific antibodies, and T-cell engagers.

Stage One Therapeutics

Stage One Therapeutics is a precision oncology company focused on reprogramming myeloid biology to overcome tumor-driven immune suppression and deliver transformative therapies for cancer patients.

CrossBridge Bio

At the forefront of Antibody-Drug Conjugate technology platform, Crossbridge Bio delivers innovative therapeutic results for patients.

Bectas Therapeutics

Bectas Therapeutics is a preclinical-stage biotech company developing monoclonal antibody therapies for cancer.

biotx

Biotx.ai uses AI and human genetic data to identify causal gene-disease links for better drug discovery.

*Portfolio includes both controlled operating companies and minority venture investments.

Have something worth building?

If you’re developing breakthrough science and want a partner to help bring it forward, we’d love to hear from you.